Difference between revisions of "File:Fig3 Pickering LancetMicrobe2021 2-9.jpg"
Shawndouglas (talk | contribs) |
Shawndouglas (talk | contribs) (Added summary.) |
||
| Line 1: | Line 1: | ||
==Summary== | |||
{{Information | |||
|Description='''Figure 3.''' Comparative evaluation of antigen test sensitivity for the B.1.1.7 variant versus non-B.1.1.7 variant. Combined nasopharyngeal swabs were obtained from 23 individuals with confirmed SARS-CoV-2 B.1.1.7 infection (December 2020 through January 2021) and compared with samples from before the variant was widely circulating in the U.K. population (April through September 2020). All swabs were matched for N Ct values, shown in ascending order in the graph, and tested on Innova and SureScreen-V rapid antigen tests. N = SARS-CoV-2 nucleocapsid; Ct = cycle threshold; SureScreen-V = SureScreen visual. | |||
|Source={{cite journal |title=Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: A single-centre laboratory evaluation study |journal=The Lancet Microbe |author=Pickering, S.; Batra, R.; Merrick, B. et al. |volume=2 |issue=9 |pages=e461-e471 |year=2021 |doi=10.1016/S2666-5247(21)00143-9}} | |||
|Author=Pickering, S.; Batra, R.; Merrick, B. et al. | |||
|Date=2021 | |||
|Permission=[http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International] | |||
}} | |||
== Licensing == | == Licensing == | ||
{{cc-by-4.0}} | {{cc-by-4.0}} | ||
Revision as of 18:18, 22 September 2021
Summary
| Description |
Figure 3. Comparative evaluation of antigen test sensitivity for the B.1.1.7 variant versus non-B.1.1.7 variant. Combined nasopharyngeal swabs were obtained from 23 individuals with confirmed SARS-CoV-2 B.1.1.7 infection (December 2020 through January 2021) and compared with samples from before the variant was widely circulating in the U.K. population (April through September 2020). All swabs were matched for N Ct values, shown in ascending order in the graph, and tested on Innova and SureScreen-V rapid antigen tests. N = SARS-CoV-2 nucleocapsid; Ct = cycle threshold; SureScreen-V = SureScreen visual. |
|---|---|
| Source |
Pickering, S.; Batra, R.; Merrick, B. et al. (2021). "Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: A single-centre laboratory evaluation study". The Lancet Microbe 2 (9): e461-e471. doi:10.1016/S2666-5247(21)00143-9. |
| Date |
2021 |
| Author |
Pickering, S.; Batra, R.; Merrick, B. et al. |
| Permission (Reusing this file) |
|
| Other versions |
Licensing
  |
This work is licensed under the Creative Commons Attribution 4.0 License. |
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 18:15, 22 September 2021 |  | 647 × 518 (48 KB) | Shawndouglas (talk | contribs) |
You cannot overwrite this file.
